Skip to main content

Digital Health Interventions for Pregnancy- and Childbirth-Related Posttraumatic Stress Disorder Symptoms in Postpartum Women: Systematic Review and Meta-Analysis

In brief

Digital programs reduced postpartum trauma symptoms short term, but gains faded at follow-up

In 10 randomized trials involving 1,026 postpartum women, digital interventions were linked to a moderate reduction in pregnancy- or childbirth-related PTSD symptoms immediately after treatment. The benefit was not statistically clear at follow-up, and results varied substantially across studies, so whether these programs produce lasting improvement remains uncertain.

Journal
Journal of medical Internet research (Q1)
Published
11 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Ziyin Huang, Zhengxiu Xiao, Xiaoli Liao, Haoran Wu, Junyu Long, Zhiqian Zhu, et al.
PMID
43013342
DOI
10.2196/108128

Why clinicians should know about it

  • Picked for Psychiatry and Mental Health (top studies of the week, 15 November 2026): Meta-analysis evaluates digital interventions for postpartum trauma symptoms

Abstract

BACKGROUND: Pregnancy- or childbirth-related traumatic experiences may lead to posttraumatic stress disorder (PTSD) symptoms during the postpartum period, adversely affecting women and their families. Digital health interventions may improve access to psychological support; however, evidence of their effectiveness for pregnancy- and childbirth-related posttraumatic stress disorder (PCR-PTSD) symptoms remains limited and has not been systematically synthesized. OBJECTIVE: This study aimed to evaluate the effects of digital health interventions on PCR-PTSD symptoms in postpartum women, with depressive and anxiety symptoms as secondary outcomes. METHODS: We searched 7 English-language and 4 Chinese-language databases from inception through April 30, 2026, to identify randomized controlled trials (RCTs) evaluating digital health interventions in women who had experienced pregnancy- or childbirth-related traumatic events and were assessed for PTSD symptoms during the postpartum period. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Effect estimates were pooled using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustments and reported as standardized mean differences (SMDs) with 95% CIs. Statistical heterogeneity, 95% prediction intervals (PIs), subgroup effects, and the robustness of pooled estimates were also examined. RESULTS: A total of 10 RCTs involving 1026 participants were included. Of these, 9 trials (809 participants) reported PTSD symptom outcomes immediately after the intervention, and 6 trials (413 participants) reported outcomes at follow-up. Digital health interventions were associated with lower PTSD symptom severity immediately after the intervention (SMD -0.59, 95% CI -0.98 to -0.19, 95% PI -1.72 to 0.54; P=.01), with substantial heterogeneity (I²=79.86%). However, the pooled effect was not statistically significant at the longest available follow-up (SMD -0.36, 95% CI -1 to 0.27, 95% PI -2.03 to 1.31; P=.20). All 95% PIs crossed the null. No statistically significant subgroup differences were observed by PTSD-related eligibility requirements, delivery modality, intervention duration, or trauma context. A statistically significant subgroup difference was observed by health care provider involvement (Q=14.46; P<.001); however, this exploratory finding should be interpreted cautiously. Sensitivity analyses supported the robustness of the pooled effect on PTSD symptoms immediately after the intervention. CONCLUSIONS: Digital health interventions may be associated with short-term reductions in PTSD, depressive, and anxiety symptoms among women with pregnancy- or childbirth-related trauma. However, substantial heterogeneity and PIs crossing the null limit confidence in these effects. Further well-designed trials with clinically interpretable outcomes and longer follow-up are needed. TRIAL REGISTRATION: PROSPERO CRD420261290528; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261290528.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.